Creasallis
PrivateLast Round
Pre Seed
Mar 24, 2026
Total Funding Raised
$1.01M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Creasallis operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Pre Seed round in March 2026.
Creasallis is a biotechnology company that develops innovative antibody engineering solutions to improve the penetration of therapeutic antibodies into solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Creasallis Comparables
Compare Creasallis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbTx | 79% | |
| Avidicure | 72% | |
| Neobe Therapeutics | 65% |
For institutional investors. Book with your work email.
Creasallis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 24, 2026 | ||||
| Pre Seed | Jan 26, 2023 | ||||
| Accelerator | Sep 27, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Creasallis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BlueYard Capital | Pre Seed |
| ZAKA VC | Pre Seed |
| Accelerate@Babraham | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors grew 291% MoM, from 329 to 1.3K.
- Mar 24, 2026
$1M raised in Pre Seed round.
For institutional investors. Book with your work email.
Creasallis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Creasallis's valuation, stock price, and market status.
Is Creasallis a public or private company?
Creasallis is a private company.
What is the current stock price of Creasallis?
Creasallis is a private company, so its shares have no public market price. Caplight tracks Creasallis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Creasallis worth (valuation)?
Valuation information for Creasallis is not publicly available.
Can I buy Creasallis stock?
Creasallis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Creasallis's last funding round?
Creasallis's most recent funding round was Pre Seed on March 24, 2026.
Who are the main investors in Creasallis?
Key investors in Creasallis include BlueYard Capital.
Will Creasallis IPO soon?
No public IPO plans have been announced for Creasallis.
How can I track Creasallis secondary market activity?
Caplight tracks bids, offers, and trades in Creasallis's shares on secondary markets.